MENINGITIS; THE RESIDENT GUEST AND THE HEALTH CARE SYSTEM IN NIGERIA (A CASE OF 2017)

Main Article Content

ALERUCHI CHUKU
BUKOLA AJIDE
LILLIAN ADOGO

Abstract

This article seeks to review the preparedness of the health care system in the last outbreak of meningitis in Nigeria that has come to be our residential guest. Nigeria is one of the 26 countries within the extensive region of sub-Saharan Africa known as the "meningitis belt," where large epidemics occur. The outbreaks peak in the dry season in certain states is due to the low humidity and dusty conditions and usually end as the rainy season approaches, Meningitis is a tough disease and it is associated with overcrowding, which is why Nigeria records some of the highest incidences of the disease on the continent. Concerted efforts should centre on bringing the outbreak under control, as all stalk holders must work towards preventing outbreaks of this scale in the future. It is expected that States takes ownership of outbreak preparedness and ensure that all efforts put into preparedness translate to meaningful action for response. Hence local and international collaborations cannot be over emphasized in managing the epidemic.

Keywords:
Meningitis, outbreak, resident guest, season, Nigeria

Article Details

How to Cite
CHUKU, A., AJIDE, B., & ADOGO, L. (2019). MENINGITIS; THE RESIDENT GUEST AND THE HEALTH CARE SYSTEM IN NIGERIA (A CASE OF 2017). Asian Journal of Microbiology and Biotechnology, 4(2), 46-50. Retrieved from http://www.ikprress.org/index.php/AJMAB/article/view/4672
Section
Review Article

References

Greenwood B. Manson lecture. Meningococcal meningitis in Africa. Trans R Soc Trop Me Hyg. 1999;93(4):341–353.

Boade Akinola. Cerebrospinal meningitis (Csm) outbreak in Nigeria. A Public Advisory from the Federal Ministry of Health; 2017.

World Health Organization. Control of epidemic meningococcal disease. WHO practical guidelines. 2nd Edn. Geneva: World Health Organization; 1998.

Mohammed I, Nasidi A, Alkali AS, Garbati MA, Ajayi-Obe EK, Audu KA. A severe epidemic of meningococcal meningitis in Nigeria. Transactions of the Royal Society of Tropical Medicine and Hygiene. 1996;9(3): 265–270.

Frasch CE, Kapre SV, Lee CH, Préaud JM. Technical development of a new meningococcal conjugate vaccine. Clin Infect Dis. 2015;61(Suppl 5):S404–9.

Peltola H. Meningococcal disease: Still with us. Rev Infect Dis. 1983;5(1):71–91.

Lingani C, Bergeron-Caron C, Stuart JM, Fernandez K, Djingarey MH, Ronveaux O. Meningococcal meningitis surveillance in the African meningitis belt. Clin Infect Dis. 2015;61(Suppl -5):#S410–5.

Matazu K. PRO/EDR> Meningitis, meningococcal - Nigeria. ProMED Mail [Internet]; 2011.
Available:http://www.promedmail.org/

Hoop M. PRO/EDR> Meningitis, meningococcal - Nigeria: Serogroup C. ProMed Mail [Internet]; 2015.
Available:http://www.promedmail.org/

Al-Tawfiq JA, Clark TA, Memish ZA. Meningococcal disease: The organism, clinical presentation, and worldwide epidemiology. J Travel Med. 2010;17:3–8.

Kriz P, Wieffer H, Holl K, Rosenlund M, Budhia S, Vyse A. Changing epidemiology of meningococcal disease in Europe from the mid-20th to the early 21st Century. Expert Rev Vaccines. 2011;10:1477–86.

Demina AA, Pokrovskij VI, Iljina TI, Larina LI, Devjakina NP. Surveillance of meningococcal infections and other forms of purulent meningitis: A 4-year study in the USSR. Bull World Health Organ. 1986;64: 263–9.

Harrison LH, Trotter CL, Ramsay ME. Global epidemiology of meningococcal disease. Vaccine. 2009;2:B51–63.

Pollard AJ. Global epidemiology of meningococcal disease and vaccine efficacy. Pediatr Infect Dis J. 2004;23:S274–9.
Available:/factsheets/fs141/en/#

De Costa Gilbert. Health Officials Say Meningitis Ravaging Northern Nigeria. VOA; 2009.
(Retrieved 2009-03-15)

World Health Organisation. Meningococcal meningitis. Fact Sheet No. 141; 2005.
Available:http://www.who.int/mediacentre/factsheets/fs141/en/#

Kristinsen AP, Diomande F, Wei CS, Oue´draogo R, Sangare L, Sanou I. Baseline meningococcal carriage in Burkina Faso before the introduction of a meningococcal serogroup A conjugate vaccine. Clin Vaccine Immunol. 2011;18:435–43.

Agence France-Presse. West African meningitis outbreak kills 931; 2009.
(Retrieved 2009-03-15)

World Health Organisation. Meningococcal meningitis. Fact Sheet No. 141; 2005.
Available:http://www.who.int/mediacentre

Campagne G, Schuchat A, Djibo S, Ousséini A, Cissé L, Chippaux JP. Epidemiology of bacterial meningitis in Niamey, Niger. Bull World Health Organ. 1999;77(6):499–508.

Gudina EK, Tesfaye M, Adane A, Lemma K, Shibiru T, Pfister HW. Challenges of bacterial meningitis case management in low income settings: An experience from Ethiopia. Trop Med Int Health. 2016;21(7):870– 878.

Weekly Epidemiological Report. 2017;7(21).